Proton pump inhibitor: The dual role in gastric cancer
Volume: 25, Issue: 17, Pages: 2058 - 2070
Published: May 7, 2019
Abstract
Proton pump inhibitors (PPIs) are one of the most frequently used medications for upper gastrointestinal diseases. However, a number of physicians have raised concern about the serious side effects of long-term use of PPIs, including the development of gastric cancer. Recent epidemiological studies have reported a significant association between long-term PPI intake and the risk of gastric cancer, even after successful Helicobacter pylori...
Paper Details
Title
Proton pump inhibitor: The dual role in gastric cancer
Published Date
May 7, 2019
Volume
25
Issue
17
Pages
2058 - 2070
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History